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m1 Epidemiology of immunity to diphtheria in 
Poland 
J. Walory', P. Grzesiowski2, W Hryniewicz'. 'Sera and Eccines 
Central Rexarch Laboratory, 211niversity Medical Sclzool, Warsaw, Poland 
Introduction: Outbreaks of diphtheria noted in countries of the 
former Soviet Union have led to the new epidemiologic situation in 
Europe. The risk of transmission of the disease to neighboring coum- 
tries depends on the immunity against diphtheria in this population. 
Objectives: To evaluate immunity to diphtheria in healthy adults 
from different regions of Poland. 
Materials and methods: Diphtheria antitoxin level was tested 
in 2167 blood samples by enzyme immunoassay (toxoid ELISA). 
Antitoxin titer was calibrated by the W H O  standard for human diph- 
theria antitoxin. For calibration, as a reference method, the neutral- 
ization test of toxin on Vero cells was used. 
Results: In the eastern region of Poland there were significantly 
less individuals who completely lacked immunity to diphtheria (<O.  1 
IU/mL) (149/866, 17%) in comparison to the central region 
(1 10/5Y4, 20%) and western region (170/707, 24%)). The majority 
of non-protected individuals (90%) were adults between 30 and 75 
years of age. In protected individuals no significant differences in 
mean, median and GMT of diphtheria antitoxin levels were observed 
among sexes and regions. 
Conclusions: A higher overall rate of protection in the popula- 
tion of the eastern region of Poland in comparison to other regions 
waq revealed. The difference is probably due to the higher frequency 
of contacts with the natural reservoir of bacteria and Russian 
epidemics. We suggest routine booster immunization in people older 
than 30 years from regions with high rates of ongoing migration. 
Ip3801 Primary actinomycosis of the hand: a case 
report 
A. Mert', H. Bahar, M. Torun*, E Tabakl, M. Basaranoglu. 
'Department of Clinical Bacteriology and hfertious Diseases, 'Department 
.f Cliniral Microbiology and Microbiolqy, Cerrahpasa Medical Faculty, 
Istarrbul Uniurrsity, I ~ t a ~ b ~ l ,  7iukey 
Objectives: Primary actinomycosis of an extremity is very uncoin- 
mon. We present a case occurring in the hand. 
Case report: A 35-year-old man was admitted to the hospital 
because of a 6-month history of increasing pain, swelling with 
erythema, and indurated nodules with intermittent discharge on the 
dorsum and plantar surface of his right hand. There was not a clear 
history of trauma to the hand. N o  antibiotics were taken in this 
period. Results of the patient's physical examination were normal 
except for his right hand, which was swollen dorsally and plantarly 
over the second, third and fourth metacarpals There were three 
nodules associated with fluctuance surrounded by enduration, and 
erythema in this region. Routine laboratory work was unremarkable. 
X-ray fihn and N R  imaging of the right hand showed changes 
consistent with osteomyelitis of the right second, third and fourth 
proximal metacarpals. Under local anesthetic, the niast was incised 
and curettrd. Serosanguinous exudate and granulation tissue imprint- 
ing was sent for culturing and histologic examination. Gram stain of 
exudate and tissue revealed polyinorphonuclear leukocytes, and 
nunierous branching, filamentous, Gram-positive rods. Cultures of 
these specimens yielded Actinomyces itraelii. Histologic examination 
was consistent with actinomycosis. Afrer the adnuuistration of ampi- 
cillin intravenously, 12 gdaily, for a month, doxycyiine (200 mg daily) 
was started due to drug reactions against ampicillin and will be 
continued for 11 months. At the third month of therapy, partial clin- 
ical improvement was obtained. 
Conclusions: Increased awareness of actinomycosis is required in 
the differential diagnosis of any subacute or chronic inflammatory 
lesion involving soft tissues and progressing to osteomyelitis in the 
hand. 
Sexually-transmitted diseases (STD) and 
chlamydia1 diagnostics 
Ip3811 The development of a thermophilic strand 
displacement amplification (SDA) system for 
Neisseria gonorrhoeae using fluorescent 
energy transfer 
C. liostkowski, D. Berger, S. Bustos, G. Durniowicz, T. Fort, t? 
Foxall, J.M. Harris, K. Williams, K. 13. Yanson, D. Yurtis, Brrton 
Dirkinson Mirrobiolqy, Molecular Diu~lnoziirs, Sparkz, USA 
Objectives: A specific and sensitive homogeneous fluorescent ther- 
mophilic strand displacement amplification (SDA) assay for the detec- 
tion of Neisseria pnorrhoeae (GC) was developed for use on the 
EDProbeTec ET. This system can be used for the detection of G C  
in urine samples and urogenital swabs. 
Methods: The 103 base pair genomic target region was amplified 
and simultaneously detected during amplification using fluorescent 
energy transfer. Reaction components were optimized uPing a statis- 
tically designed approach to improve performance. The sample- 
processing procedure, compatible with the SDA fluorescent system, 
delivers target from urine and urogenital swabs. 
Results: The analytic sensitivity of the GC SDA system is approx- 
imately 10 CFUs per reaction. The specificity of the GC system is 
100% in all strains tested, with no significant cross-reactivity to any 
of the 45 potential cross-reactants tested. In-house preliminary ttud- 
ies with a limited number of clinical samples produced the following 
sensitivity/specificity data when samples were processed according to 
the described procedures: female swabs 96.4'%r/100%; male swabs 
100%/100%; female urines 100%/100%; male urines %.40/;,/%.6'%1. 
Conclusions: The sensitivity and specificity of this simultaneous 
detection and amplification system form the basis for a utcful clini- 
cal diagnostic test for the rapid detection of N. pnorrhoeae. 
lp3821 Evaluation of the discriminatory power of 
typing methods for Neisseria gonorrhoeae 
M. Van Looveren, C.A. Ison, M. Leven, K. Vermeulen, P. 
Vandamme, H.  Goossens, Utiiversity o j h t n x r p ,  Medical hlicrobiologfi 
Wilrtjk (Attwerp), Bekium 
A panel of 18 strains of Neisscria pmrrlroene, known to be teinporally 
and geographically diverse, was used to evaluate 3 nuiiiber of typing 
systems, including conventional auxotyping and serotyping and the 
molecular methods of arbitrarily primed PCR (AP-I'CK), ainpli- 
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fied ribosomal DNA restriction analysis (ARDRA), opa-typing 
(O'Rourke M, Ison CA, Renton AM, Spratt BG. Mol Microbiol 
1995; 17: 865-75), and pulsed-field gel electrophoresis (PFGE). The 
discriminatory power of the different typing methods was deter- 
mined using a collection of 87 clinical isolates from commercial sex 
workers in Indonesia and analyzed using Simpson's index of diversity 
(Hunter PR, Gaston MA. J Clin Microbiol 1988; 26: 2465-6). 
Results: O f  the two traditional techniques, serotyping was more 
hscriminatory than auxotyping, but the combination of the two 
methods gave the greatest differentiation (discriminatory index, DI 
0.928). PFGE using the restriction enzyme BglII and opa-typing 
produced the highest level of discrimination (DI 0.997 and 0.996, 
respectively). The remaining molecular methods were less discrimi- 
natory when used alone but their ability to differentiate between 
strains increased when they were combined with serotyping; for 
example, combination of serotyping with D11344-primed or 
D8635-primed PCR, resulted in a discriminatory index of 0.936 and 
0.937, respectively. ARDRA revealed a low discriminatory index (DI 
0.743) alone but one of 0.955 in combination with serotyping. 
Conclusions: Opa-typing and PFGE are highly discriminatory 
but are technically demanding and time-consuming, and hence a 
combination of serotyping and AP-PCR or ARDRA is very attrac- 
uve. 
[p3831 The new BDProbeTec ET System for 
Chlamydia trachomatis and Neisseria 
gonorrhoeae 
C.A. Gaydos', J.C. Lovchik2, S. Leister', L.Peralta2, T.C. Q ~ i n n ' . ~ .  
'JHU 'UMD, "Iff, Baltimore and Bethesda, MD, USA 
Objectives: To evaluate the performance of a new molecular-based 
simultaneous amplification and detection system employing strand 
displacement amplification (SDA) for the detection of Chlamydia 
trachomatis (CT) and Neisseria gonorrhoeae (GC) using both swab and 
urine specimens in two laboratories. 
Methods: The Becton Dickinson SDA assay (BDProbeTec ET 
System) (Becton Dickinson Microbiology Systems, Sparks, MD) was 
used to test 454 female endocervical and 91 male urethral swabs, and 
urine &om 450 females and 93 males from STD, adolescent and 
family planning clinics, for C T  and GC and compared to ligase chain 
reaction (LCR). 
Results: The C T  sensitivity and specificity for the female swabs 
were 93.1% and 97.296, and for urines 93.9% and 98.6% respectively. 
For GC, the sensitivity and specificity for female swabs were 92.7% 
and 98.5%, and for urines 84.6% and 97.9%, respectively. GC sensi- 
tivity for both male swabs and urines was 100%, and specificity was 
100% for swabs and 97.0% for urines. 
Conclusions: The BDProbeTec ET System is a highly sensitive 
and specific method to detect CT and GC in both swabs and urines. 
It is an easy-to-use, isothermal reaction, using room temperature 
reagents and ambient transport of specimens. 
Ip384j Becton Dickinson BDProbeTec ET System (BD- 
PT) for detection of Chlamydia trachometis 
(CT) and Neisseria gonorrhoeae (GCI: room 
temperature stability and comparison to ligase 
chain reaction (LCR) 
D.H. Martin', W. LeBar?, C. Cammaratal, R. Kendrick2. 'LSU 
Medical Center, New Orleans U, zHCL-Prooiderice Hospital, 
Southjeld MI, USA 
Objectives: The Becton Dickinson BDProbeTec ET System is a 
new DNA amplification methodology which uses homogeneous 
fluorescent thermophilic strand displacement for the detection of C T  
and GC. The assays include an amplification control. We determined 
room temperature stability of specimens obtained for BD-PT and 
compared initial results to the LCR assay. 
Methods: Specimens were obtained from STD clinic patients. A 
swab for the LCR assay and four swabs for the BD-PT assay were 
obtained from the endocervix of 226 women. Urine specimens were 
obtained from 37 men and 150 women. Initial assays for BD-PT and 
LCR were processed within 24 h of collection. The remaining spec- 
imens for BD-PT were held at room temperature for 2 ,4  and 5 days. 
Results of testing at additional time-points were compared to the 
original BD-PT results. 
Results: Overall, there was 94% agreement of BD-PT and LCR 
for the detection of C T  and 97% agreement for the detection of GC. 
Holding specimens at room temperature for from 2 to 5 days resulted 
in disagreement with initial BD-PT results in 0-7% of cases. There 
were no trends toward increased disagreement over time by organ- 
ism, specimen type and original result. Increased inhibition (indeter- 
minate results) in urine specimens over time for C T  and GC was 
observed. 
Conclusions: BD-PT correlates well with LCR. Swab and urine 
specimens for BD-PT are stable for up to 5 days at room tempera- 
ture. Urine reportable results are slightly decreased over time due to 
a slight increase of inhibitors. 
lp3851 Amplification automation of the VIDAS Probe 
Neisseria gonorrhoeae Test 
M. Longiaru, E. Burres, M. Gilker, S. Santa Ana, T. Wang, B. 
Rice. Gen-Probe Incorporated, Son Diego, CA; bioMerieux, Znc., 
Rockland, MA, USA 
Objectives: To automate transcription mediated amplification 
(TMA) and detection of Neisseria gonorrhoeae (NG) ribosomal RNA 
(rRNA) on a VIDAS strip using a small station for amplification 
(AMPstation). 
Methods: Processed samples are added to disposable VIDAS 
Probe strips containing all reagents necessary for amplification and 
detection. In the AMPstation, the strip becomes the site for an auto- 
mated, closed system TMA reaction which amplifies NG rRNA. 
The VIDAS Probe Neisseria gonorrhoeae Test also contains an internal 
control which co-amplifies and monitors inhibition of amplification. 
Detection in the VIDAS instrument utilizes solid-phase capture of 
amplified product and specific fluorescent-labeled reporter probes. 
Time to results is less than 4 h, including sample processing. As part 
of an ongoing study, 133 clinical endocervical swabs were tested at 
Gen-Probe using this method and compared to culture results for 
NG. 
Results: One hundred and six of 11 1 (95.5%) NG culture-nega- 
tive clinical swabs were also negative in the VIDAS Probe Neisseria 
gonorrhoeae Test. The remaining five culture-negative swabs were 
positive in the VIDAS assay and also positive using the direct 
hybridization PACE-2 NG test. Twenty-two of 22 (100%) NG 
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culture-positive swabs were also positive in the VIDAS assay. N o  
internal control amplification failures were seen. 
Conclusions: The  VIDAS Probe Neisscria gonorrkoene Test, co- 
developed by Gen-Probe and bioMerieux, is a sensitive method for 
detection of N G  rRNA. The  automated format, unit dose reagents, 
closed amplification system and incorporation of an internal control 
provide additional convenience for the clinical laboratory. 
Lp3861 Development of an automated, amplified 
VIDAS Probe test for the simultaneous 
detection of Neisseria gonorrhoea and 
Chlamydia trachomatis 
W. Lauzier', M. Morin', T. Wang', G. McKinley', E. Burres', G. 
Burns', L. Catanzariti', E? Levasseur'. 'BioMerieux, h i . ,  Rorklawd, 
M A ,  'Gctr-Probe h i . ,  San Diqo, CA, U S A  
Objectives: To develop a screening assay for the detection of N .  
gonorrkocn (NC) and/or C. trackomatis (CT) ribosomal R N A  (rRNA) 
with an internal control R N A  (IC) in an automated system. 
Methods: Processed samples are added to disposable VIDAS 
Probe strips containing amplification and detection reagents. The 
VIDAS strips are placed in an instrument (AMPstation) which auto- 
niates Geii-Probe's transcription-mediated amplification (TMA), CT, 
N G  and IC R N A  are co-amplified. The amplified products are 
detected in bioMerieux's VlDAS Immunoassay System. As part of an 
ongoing study, clinical swab samples (endocervical, vaginal or 
urethal) were tested and compared to culture or Cen-Probe's PACE 
Results: 46 of 77 C T / N G  PACE-negative clinical swabs were also 
negative in the VIDAS test. 29 (100%) PACE-positive samples were 
also positive in the VIDAS test. One sample was negative with PACE 
but tested positive with the amplified VIDAS N G / C T  test. The 
remaining saiiiple was identified as an amplification failure by the I<: 
system. h6 of 109 C T / N G  culture-negative clinical swabs were also 
negative in the VIDAS C O M B O  test. 36 (97%) culture-positive 
samples were also positive in the VIDAS test. Three samples were 
negative with culture but positive with the amplified VIDAS test and 
PACE. The  remaining three samples were identified as amplification 
failures by the IC system. 
Conclusions: The VIDAS screening test is a sensitive method for 
the detection of N G / C T  rKNA. The automated format and recou- 
binaiit internal control will provide an additional tool for the screen- 
ing of STDs in clinical laboratories. 
test. 
Lp3871 Thermophilic strand displacement 
amplification of Chlamydia trachomatis using 
fluorescent energy transfer 
D. Berge, S .  Bustos, G. Durmowicz, T. Fort, P. Foxall, J. Harris, C. 
Rostkowski, K. Williams, K. D. Yanson, D. Yursis. Beiton Diikinson 
Miirobiolqy Systenis, Sparks, MD, USA 
Objectives: Here we describe the development of a theriiiophilic 
strand displacement amplification (SDA) system for the detection of 
Cklamydia traikoniaks (CT) for use on the UD ProbeTeC ET System. 
Methods: The system amplifies a 100-bp fragment of the 7.5-kb 
CT cryptic plasmid. Amplification and detection occur simultane- 
ously in the reaction, eliminating post-amplification manipulation of  
the reactions. Real-time detection is made possible through the use 
of a specially designed detector probe which utilizes the energy trans- 
fer behavior of fluorescent emission. Assay performance was opti- 
mized by evaluating components of the system in statistically 
designed experiments. Sample-processing techniques were developed 
and tested. 
Results: The specificity of the CT SLlA system was demonstrated 
by detecting all 15 CT serovars (100%) with no significant cross-reac- 
tivity when challenged with 43 potential contaminants and urogen- 
ital pathogens in a clean system. Under the optimal reaction 
conditions, the analytic sensitivity in a clean system was Icsj than (1.1 
IFU/reaction. In-house preliminary studies with a limited number of 
clinical samples produced the following sensitivity/specificity data 
when samples were processed according to the described procedures: 
female swabc 100%1/100%~; male swabs 89%/90'%; femalc urine 
9 5 W  100%; male urine 94'%/92%. 
Conclusions: Real-time detection of tSDA and streamlined 
sample processing produced good sensitivity and specificity, and 
provided the basis for an effective clinical diagnostic teyt for thc rapid 
detection of Cklaniydia trarhomatis on the BD ProbeTeC ET System. 
(p3881 Screening of clients of sex-workers for 
Chlamydia trachomatis by ligase chain reaction 
in Istanbul 
A. Agaqfidaii, M. &el, N. Isik, S. Badur, 0. Ang. Istmhir/ F d t y  
of Medirinc, Drpnrtrncrrt ifA4icrobioliig~ I w h l ,  %key 
Cklantydin fratltoinatis is the most common sexually transmitted bacte- 
rial pnthogen. The greatest risk for this infection is almost always 
associated with prostitution. Sex-workers and their clients have a 
potential risk for urogenital Chlamydia1 infection. 
In this study, 301 male patients with urethritis were screened for 
C. rrdckonintis by ligase chain reaction (LCR) (Abbott LCx C. 
rraihonratis assay). Patients applied to our department, arid stated that 
they had had sexual contact with sex-workers. A urethral specimen 
obtained from each male patient was pldced into an STD swab traiis- 
port tube (LCx, Abbott). The LCR test was performed according to 
the manufacturer's instructions. The treated swab specimens in  the 
transport tubcs were heated at 97'C for 15 niiii. For amplification of 
Cklanzydia by LCx, 100 pL of the treated specimens wa\ used. An 
LCx analyzer was used to detect the amplicons. I t  also calculated the 
cut-off value, and specimens with an assay value equal to or greater 
than the cut-off value were considered positive. 
Chlamydia1 infection frequency among this group was Ih'%. 
Further surveys of this population are needed to determine the inci- 
dence and prevalence of urogenital chlamydia1 infections and other 
STDs. 
(p3891 Comparison of the direct fluorescent antibody 
(DFA) and optic immunoassay (OIA) results 
with cell culture method for the detection of 
Chlamydia trachomatis from endocervical 
specimens 
I .  Mehniet, A. Uktem, I .  Hakki Bahar, N. Yulug. Dokirz Eylii 
University Fairrlty qf Medicine, Mirrobiolqqy arid Cliniinl Microkioloecy 
Departnicnt Izmir, Turkey 
Chlamydiae are non-motile, small, bacterial pathogens that were 
once mi3takcnly thought to be viruses because of their obligJte intra- 
cellular cell life cycle. Cklanzydia trarkonrntis (C. traikonintis) is known 
to be the most conimon bacterial wxually transmitted disease (STD). 
Worldwidc it is estimated that there are more than 50 million new 
cases annually. We do not know the status of C. tunikontatis infcction 
in Turkey and we need new broad-based data on the infection. In 
this study, we used two screening methods: direct fluorescent anti- 
body (DFA) and optical iiiiinunoassay based enzyme Immunoas\ay 
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technique and one gold standard (cycloheximide-treated McCoy cell 
culture in shell vials) method. We detected C. trackomatis in 24 
patients of 75 (32%) with cervical infection with the cell culture 
method and compared two screening methods for sensitivity, speci- 
ficity, PPV and NPV 71%, 100%, 86% and 100% for DFA, and 75% 
86%, 72% and 88% for OIA, respectively. When the results were eval- 
uated, the DFA method was shown to be more effective than OIA 
for the screening of C. trackomatis in our laboratory, as OIAs exhibit 
many false-positive results and all positive results of OIAs have to be 
confirmed with reference methods. 
Detection of urogenital Chlamydia frachomafis 
infection 
K. Avdeliodi, H. Kada, M. Simou, I. Glynou, H. Nicolaou, 
General and Maternity Hospital, Microbiology, Atkens, Greece 
Objectives: (1) To determine the prevalence of C. trachomatis in 
symptomatic and asymptomatic women by testing endocervical spec- 
imens, and (2) to test urine for C. trackomatis. 
Methods: A total of 523 endocervical specimens from women 
(155 symptomatic and 368 asymptomatic) who attended the 
Outpatient Department of our hospital were tested by the LCR 
method (ABBOTT LCx C. trackomatis assay). In addition, 69 paired 
urine and endocervical swab specimens were tested by LCR for C. 
trackomatis. For every case, a questionnaire was completed for infor- 
mation about age, nationality, education and sexual behavior of the 
patient. 
Results: Of 523 women tested, 39 (7.5%) were positive for C. 
trackomatis. 18% (7/39) of C. trackomatis-positive women had co- 
infection with Ureaplasma urealyticum and/or Mycoplasma kominis. Of 
the 39 positive women, 6 (15%) were foreigners, 18 (46%) were 
symptomatic and about 50% had low or medium educational level. 
Of  69 paired urine and swab specimens, 3 were positive and 65 nega- 
tive. Only 1 pair gave different results (positive in swab, negative in 
urine). 
Conclusions: The prevalence of C. trackomatis in the studled 
population is 7.5%. In order to reduce the problem, both sympto- 
matic and asymptomatic women should be tested with sensitive assays 
such as LCR and should be treated immediately. Endocervical swabs 
and urine samples can both be used as specimens for testing. The 
Abbott LCx Chlamydia assay is very sensitive and easy to handle and, 
therefore, well suited for testing patients with or without symptoms 
of C. trackomatis infection. 
Application of Amplicor CT Test for detection 
of Chlamydia frachomatis by pooling 
endocervical swabs and urine specimens 
obtained from the same patient 
M. Bogard, C. Claise, B. Chougnet-Daffos, D. Lefort-Lkger, E. 
Plouvier, M. Louvet, G. Glikmanas, E Thuillier. C.H. G., Meanx, 
France 
Objectives: To evaluate the performances of the Amplicor C T  PCR 
assay (Roche Diagnostics) on pooled genitourinary specimens for the 
detection of Chlamydia trachomatis (CT). 
Methods: A consecutive population of 133 asymptomatic women 
attending the family planning cllinic of Meaux entered the study. 
Endocervical swab specimens (ECS) and FVU were separately 
processed according to the manufacturer's instructions. In parallel, a 
concomitant pooling of specimens was performed: 125 pL of swab 
specimen was added to the pellet obtained after centrifugation of 500 
pL of washed FVU. The subsequent steps consisted of successive 
additions of 125 pL of lysis buffer and of 250 pL of specimen dilu- 
ent. Finally, a 50-pL volume of each extract was amplified and 
detected on automated PCR instrument Cobas Amplicor. 
Results: An overall prevalence of 4.5 % (61133) was observed for 
C T  infection. Results are expressed as follows (ECS, FVU, pooled 
ECS=FVU: number ofpatients): -, -, -: n=127; +, +, +: n=3; 
+, -, +: n = l ;  +, -*, -*: n=l ;  -, +, +: n=l). *Repeatedlyposi- 
tive when retested in six separate experiments. 
Conclusions: Our preliminary results suggest that the pooling of 
ECS and FVU specimens in order to perform only one PCR/detec- 
tion allows detection of C T  in genitourinary specimens with a sensi- 
tivity at least similar to those of PCR performed separately on ECS 
and FVU. Moreover, it should be noticed that inhibition rate was 
dramatically decreased in pooled specimens when compared to FVU 
processed alone (0% versus 5.3% in our study). 
A novel instrument and disposable for 
transcription-mediated amplification of 
Chlamydia trachomatis rRNA 
M. Vera-Garcia', J. Burns2, A. Hern', G. McKinley', A. Traverse', 
I? Wells', L. Catanzariti'. 'bioMerieux, Inc., Rockland, MA, 2Gen- 
Probe Incorporated, San Diego, CA, USA 
Objectives: To automate amplification and detection of C. trackoma- 
fir rRNA in an automated closed system designed to minimize cont- 
amination. 
Methods: Processed samples are added to disposable VIDAS 
Probe strips containing unit dose amplification and detection 
reagents. The VIDAS strips are placed in an instrument 
(AMPstation), which automates Gen-Probe's isothermal transcrip- 
tion-mediated amplification (TMA). C. trackomatis rRNA and an 
internal control RNA are co-amplified, and the amplified products 
are detected using alkaline phosphatase-labeled reporter probes on 
bioMerieux's VIDAS Immunoassay System. Time to results is less 
than 4 h. 
Results: As part of an ongoing study, a total of 145 clinical spec- 
imens were tested by the amplified VIDAS Probe test and compared 
to Gen-Probe's amplified C. trackomatis test. The samples consisted 
of 50 endocervical swabs, 38 vaginal swabs (matched with endocer- 
vical swabs collected from the same patient), 29 urethral swabs and 
28 male urines. The VIDAS Probe test identified 16 culture-positive 
endocervical swabs, 4 culture-positive male urethral swabs and 7 posi- 
tive male urines. Six additional culture-negative samples (3 urethral, 
3 endocervical) were identified as positive by both the VIDAS and 
Gen-Probe's amplified C. trackomatis test. The data showed 100% 
agreement between endocervical and vaginal swabs. No internal 
control amplification failures were seen for endocervical swabs, vagi- 
nal swabs, male urethral swabs and male urines. 
Conclusions: The Vidas Probe C. trackomatis test, co-developed 
by bioMerieux and Gen-Probe, is a sensitive method for the detec- 
tion of C. trackomatis rRNA. The automated format, unit dose 
reagents, closed amplification system and incorporation of an inter- 
nal control provide additional convenience for the clinical laboratory. 
I=) Chlamydia frachomafis infection in pregnancy: 
optimal time for sampling 
A. Sensini, A. Ulissi, M. Tristani, E Bistoni, G. Clerici, G.C. Di- 
Renzo. University of Penrgia, Perugia, Italy 
Objectives: To evaluate the incidence of C. trachomatis infection in 
pregnant women and to verify the optimal time for sample collec- 
tion. 
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Methods: From January 1995 to June 1997,668 pregnant women 
were subjected to microbiological screening and anamnestic data 
were obtained. Endocervical and endourethral swabs were collected. 
Samples were niaintained in 2SP transport medium until inoculation 
in 96-well microplate McCoy monolayers. Identification of C. 
tmchomatis-infected cells was performed using DNA probe against 
rRNA. Antimicrobial therapy was administered to infected women. 
Results: The overall incidence of C. tmrliomnfis infecuon was 
6.4%, ranging from 4.9% in 1995 to  7.4% in 1996/97. The incidence 
of infection was evaluated in relation to the trimester of pregnancy. 
The highest value was reported in the 2nd trimester (7.7%). In 
1996/97, when an increase of infection was observed, the percent- 
age of infected women in the 2nd trimester was significantly greater 
with respect to the 1st trimester (9.7% versus 3.7%). although simi- 
lar to the 3rd trimester (7.9%). The incidence of infection in symp- 
tomatic and asymptomatic women was 5.9% and 7.4% respectively 
Conclusions: The observed incidence of C. trachorriatis infection 
justifies a screening program for pregnant women. However, genital 
samples should be collected in the 2nd and 3rd trimesters, regardless 
of the presence of cyniptoms. 
1 P394 ] Interest of detecting infections due to 
Chlamydia trachomatis in patients undergoing 
elective abortion 
J.M. Sueur', J Mention', J. Ortila'. 'Biobanle qfPicardy, 'Center .f 
OBstetrical Gynecology, Amirnr, Franre 
Objectives: To measure the prevalence of infections due to C. 
tracitomatis in patients undergoing elective abortion. Knowing the 
prevalence will enable orientation of therapy: systematic treatment if 
the prevalence is 6x1, systematic in vitro diagnosis prior to treatment 
if the prevalence is 3%. 
Methods: Diagnosis of a C. trachomafis infection is performed 
using both a molecular biology technique (AMP CT, Gen-Probe) on 
first voided urine samples, and an immunoglobulin detection tech- 
nique (Wang and Grayston Microimmunofluorescence IgG and IgA, 
and IinniunoComb, PBS Orgenics). The presence of immunoglob- 
ulins enables differentiation between very recent infections (negative 
serology) and former infections (pocitive serology), and therefore 
short- or long-course therapy can be initiated. The presence of 1gA 
may indicate an active infection. The study includes 200 specimens 
collected from October 1998 onwards. 
Results: To date, 64 cpecimens have been tested in parallel. 
Among these, 52 (81%) were found to be negative by three meth- 
ods. O f  the 12 patients with a positive seroloby, 7 (1 1%) showed signs 
of former infection, 3 (5%) showed signs of an active upper tract 
infection and 2 (3%) showed signs of lower tract infection. Only the 
latter two patients gave a positive recult for AMP CT 
Conclusion: These preliminary results show the interest of asso- 
ciating serology (both IgG and 1gA) and molecular biology to detect 
both upper and lower tract C. trachomatis infections, to cover the pre- 
serologic window, and to initiate early treatment in order to avoid 
clinical complications. 
Detection of HPV DNAs types 6, 11,16, 18,31 
and 33 in intraepithelial female genital lesions 
by PCR-ELISA 
S. Venturoli', E. Manaresi', G. Gentile', S. Costa', M. Musiani', 
M. Zerbini'. 'Deportmenf .f Clinical and Experimental Medicinr, 
'Depaufment of Obstetrics and Gynccoloy~ Universtty 4 Bologna, Italp 
Human papillomavirus (HPV) infections are related to tcveral cuta- 
neous and mucosal dysplasias, including both benign and malignant 
lesions. Kecent developments in HPV DNA detection technique5 
have shown that HPV infections in the female genital tract are 
common but the progression ofthe disease may require several factort 
such as the persistence of the infection, the viral load, co-infection 
with multiple HPV genotypes, the prevmce of inimuiiode~ciciicies 
and possibly the presence of other cofactors. We performed a semi- 
quantitative PCR-ELISA assay to detect and type the high, iriter- 
mcdiate and low oncogenic risk HPVs 16,18; 31 3 3 ;  6 , l l  respectively 
in cytologic and biopsy specimens of the female genital tract. The 
study population comprised: HIV-seronegative women with low- 
and high-grade intraepithelial lesions and HIV-seropositive women 
with high-grade intraepithelial lesions. Intraepithelial lesions were 
determined on  the basis of clinical, cytologic and/or histologic find- 
ings. Sixtytwo samples were analyzed from 56 patients with low- 
grade lesions and 74 from 67 patients with high-grade lesions; both 
groups proved to be HIV seronegative. 41.9% and 60.8% of the 
samples from low- and high-grade lesions respectively proved posi- 
tive for HPV DNAs. The most comnion genotype was 16 i n  both 
group$ and only in three cases of high-grade lesions were two differ- 
ent HPV genotypes detected in the same sample. Moreover, 23 
samples from 18 HIV- seropositive wonien with high-grade genital 
lesions were investigated. 65.2% of the samples tested proved positive 
for HPV DNAs; the most frequent genotype was 16 and three 
samples proved positive for two different genotypes concomitantly. 
In HIV-seropositive patients, HPVlH was detected with an incidence 
higher thaii in the two HIV-seronegative groups. 
(p3961 PCR detection of human papillomavirus (HPV) 
in cervical intraepithelial neoplasia 
M. Kassu , M. Scagnelli, G. Brusarosco, PA. Bevilocqua, E. 
Bonoldi. Sari Bortolo Hospifal, V i c e m a ,  I faly  
HPV infection plays a major role in the developnient of cancer of the 
female lower genital tract. Both imniunocytochemical (ICH) and in 
situ hybridization (ISH) are useful tools in demonstrating HPV DNA 
in pathologic tissues, but formalin fixation, paraffin embedding 2nd 
prolonged storage decrease the sensitivity of these technique?. Ute of 
PCR, due to its excellent molecular sensitivity, can optimize the 
detection of DNA. 
Objectives: (1) To correlate PCR sensitivity with hittologic grad- 
ing. (2) To evaluate and compare the sensitivity of PCK and ICH for 
detection of HPV-DNA. (3) To evaluate the effects on the sensitiv- 
ity of the two methods of paraffin storage 
Methods: 33 paraffin-embedded specimens, from sexually active 
non-HIV women (17 CIN1, 9 CIN2 and 7 CIN3) were exaniincd. 
All the cases displayed cytologic features, consistent with HPV infec- 
tion. lmniunocytochemical invectigation was perfornied employing 
the ABC method by Su et al. PCR was carried out on extracted 
DNA using the consensus primer par  MY09-11.Those cases in  
which MY-PCR failed to detect HPV DNA were evaluated by the 
GP5+/GP 6+ primer set with a'nested' reaction. 
Results: ICH allowed us to demonstrate HPV DNA, respectively, 
in 35% of C l N l ,  77.7% of C1N2 and 71.4% of CIN3. 13 out of the 
17 CINl  were positive using the MY09-11 one-step PCR and 4 only 
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by CP5-GP6 'nested' PCR. Of the 9 CIN2, 7 were positive with 
MY09-11 and 3 only with CP5-GP6, while 4 of the CIN3 were 
positive with MYO9-11 and 3 only with CP5-GP6 PCR. 
Conclusions: PCR allowed detection of HPV DNA in all the 
patients examined in comparison with the ICH method, which 
worked in 51.5% of the cases.Therefore, PCR is a reliable system 
to find all the HPV, when investigating parafin-stored tissues. 
This study was supported by Regione Veneto Research grant 
537/O1 /I  994. 
IW] HPV-DNA assay as an intermediate screening 
method 
H. Kada, S. Kanakakis, T. Lazaraki, H. Adreadi, H. Ekonomou, 
Th. Karagitsou, A. Rodolakis, General and Maternity Hospital, 
Microbiology, Athens, Greece 
Objectives: To evaluate the hybrid capture HPV-DNA assay as a 
method for identifying cervical neoplasia in high-risk patients. 
Methods: 100 women aged between 17 and 65 years with an 
abnormal pap smear were triaged by the hybrid capture assay 
(Digene) for low- (6, 11, 42, 43, 44) and high-risk (16, 18, 31, 33, 
35, 45, 51, 52, 56) types. Cytology was compatible with HGSIL in 
9 cases, LGSIL in 11 cases, ASQLJS in 18 cases, AGUS in 2 cases, 
HPV in 28 cases and inflammation in 32 cases. All these women 
subsequently underwent a colposcopic assessment. 
Results: 35 women were found to be HPV-DNA positive (28 for 
high-risk and 7 for low-risk types). The colposcopic/histologic eval- 
uation showed 2 cases with invasive Ca, 11 cases with HGSIL and 22 
with LGSIL. In 30 out of the 35 HPV-DNA-positive cases, histol- 
ogy was compatible with cervical neoplasia. Out of the 65 HPV- 
DNA-negative cases, colposcopic evaluation revealed 5 cases with 
cervical neoplasia. The sensitivity of the test for cervical neoplasia was 
85.7%. The sensitivities for HGSIL and LGSIL were 90.9% and 
81.8% respectively The overall specificity was 92.3%. 
Conclusions: It is shown that HPV-DNA detection by the hybrid 
capture assay is a reliable method for identifying patients with cervi- 
cal neoplasia. 
lp3981 Interferon is a marker for prolonged HPV 
infection 
D. Labeit, E Melchert, Universitiitsklinik Mannheim, Gynh'kologie, 
Mannheim, Germany 
Decreased immune response is necessary for a prolonged HPV infec- 
tion and allows HPV to be virulent as an oncogene. It is unknown 
whether HPV causes a localized immune depression or if an immune 
depressive state is responsible for the clinical manifestation of HPV 
infection. 
Methods: The cytokines (IFN-alpha, IFN-gamma, and TNF- 
alpha) from stimulated peripheral blood mononuclear cells (PBMCs) 
were measured using monoclonal IFN antibodies and ELISA test. To 
detect HPV-16, PCR (e6 and e7 areas) was used, followed by south- 
ern blot of the PCR products. In the total patient collective 
(N= 122), no cytologic change was observed in the cervical epithe- 
lium over a period of 3 years. A comparison was made between HPV- 
positive (N=39) and HPV-negative patients (N= 83). 
Results: Dividing the collective into HPV-16-positive and HPV- 
16-negative subgroups, the IFN-alpha values are significantly higher 
in the HPV-16-negative group (193548 U/mL) compared to the 
HPV-16-positive group (3853 U/mL, p<0.05). During a persisting 
HPV infection, there is no localized immune deficiency; however, a 
generalized reduction in immune response and decreased production 
of IFN-alpha is observed. This could explain the increased prevalence 
of HPV and associated CIN as described in the literature in the high- 
risk patients. 
Conclusions: This study shows that HPV infection in cervical 
epithelium is determined by the immune system, and IFN-alpha can 
be shown to be a prognostic parameter for the HPV infection. 
/p399/ Detection of HPV type 16 and 18 mRNA in 
peripheral blood as a marker for advanced 
cervical cancer 
Chia C. Pao , Chang Gung. University College ofMedicine, Taipei, 
Taiwan 
Objectives: To evaluate the possibility of using HPV gene expres- 
sion in peripheral blood for the detection of circulating cervical 
cancer cells in patients with locally advanced cervical cancer. 
Methods: The presence of HPV mRNA was determined by 
nested RT-PCR. Thirty-five patients with locally advanced cervical 
cancer and positive for HPV type 16 or 18 DNA were included in 
this study. 
Results: 18 of the 35 (51.4%) cervical HPV DNA+ cervical 
cancer patients were found to contain HPV-specific mRNA in their 
peripheral blood cells, whereas none of the 17 HPV DNA- cervical 
cancer patients and the 12 control volunteers did. After a median 
follow-up of 22 months, patients who were positive for peripheral 
blood HPV E6 mRNA had a significantly higher risk of recurrence 
than those who were negative (10118 versus 3/17, P=0.02; mean 
recurrent time 20.7 versus 12.6 months, P=O.01). Kaplan-Meier 
analysis showed that actuarial disease-free survival after 2 years was 
significantly lower in the cervical cancer patients who were positive 
for peripheral blood HPV E6 mRNA when compared to those who 
were negative (mean survival time 21 versus 33 months, P=0.01). 
Conclusions: The results suggest that the presence of HPV E6 
mRNA in circulating blood cells may be useful to indicate 
micrometastasis and may help to determine prognosis. 
[P4001 Specificity study of Enzygnost Syphilis on 
BEPlll 
D. Baetens, B. Weise, A. Mertens, AZ Middelheim, Lab. of Clinical 
Microbiology, Antwerp, Belgium 
Objectives: The specificity of the Enzygnost Syphilis ELISA (Dade- 
Behring) kit was evaluated by using the TPHA (Wellcosyph HA' 
1000, Murex Diagnostics) as the reference method. The analytic 
performance was also evaluated by calculating the variation coeffi- 
cients of house-made and kit controls (inter- and intra-run) and by 
evaluating the discriminatory performance of the kit. 
Materials and methods: 458 healthy blood donor serum 
samples, 1007 hospital routine samples and 96 samples positive for 
known interfering factors for syphilis testing (HIV, heterophile anti- 
bodies, Rhl  1, RA/WR, Lyme disease, anti-rnitochondrial antibod- 
ies and smooth muscle antibodies) were analyzed by ELISA (on 
the Behring ELISA Processor 111, Dade-Behring) and TPHA 
(Wellcosyph HA* 1000, Murex Diagnostics). 
Results: AU blood donor samples were ELSA negative. Six false- 
positive and 1 false-negative (FTA negative) ELISA results were found 
in the 1007 hospital routine samples. Eight of 25 Lyme disease-posi- 
tive samples, and 1 of 12 EBV-posltive samples were syphilis ELISA 
positive. CVs from inter- and intra-assays at the cut-off level were 
<9%. 
Conclusions: We concluded that the Enzygnost Syphilis ELISA 
assay is a good alternative for syphilis screening. The kit was highly 
A b s t r a c t s  1 9 1  
specific (99.6%)) and reproducibility results were acceptable. Lyine 
disease was the most frequent interfering factor. 
IP401/ Sensitivity of Enzygnost Syphilis assay on 
BEPlll 
D. Uaetens, B. Weise, A. Mertens, A2 Middellieim, Lab. @Clinical 
Micru6io/oyy, Antwarp, Be@nrn 
Objectives: The sensitivity of the Enzygnost Syphilis ELISA (Dade- 
Behring) kit was evaluated by using the TPHA (Wellcosyph HA* 
1000, Murex Diagnostics) and FTA (Bio-Merieux) as the reference 
methods. 
Materials and methods: 106 TPHA (titer=1/80) and FTA 
(titer= 1/5) positive serum samples were analyzed with Enzygnost on 
the Behring ELISA Processor I11 (Dade-Behring): 54 samples were 
VDKL negative and 52 were VDRL (titer=l/l) positive. Optical 
density ratios (cut-off/OD) of Enzygnost were compared with 
TPHA and FTA titers. 16 TPHA/FTA-positive sera from the Biotrol 
external quality control program were analyzed by the ELISA tech- 
nique. 
Results: All TI'HA- and FTA-positive samples were positive by 
the ELISA technique. There was no correlation between the ELISA 
OD ratio and the TPHA and FTA titers. A low TPHA titer can result 
in n high OD ratio and vice versa. All Biotrol samples were ELISA 
positive. 
Conclusions: In this study we concluded that the Enzygtiost 
Syphilis ELISA assay has good sensitivity (100%)) compared to the 
TPHA dnd FTA results. 
[p4021 The estimation of the usefulness of 
Mycoplasma IST test in identification and 
determination of susceptibility of Mycoplasma 
and Ureaplasma urogenital strains 
B. Maczynska'. M. Stankiewicz', M. Elias'. 'Deparlment of 
Microbiobi,y)~, 'Departmcnt cf Gynetolqy,  litiiuersity qf Medicine, 
Wruclau! Polarid 
Objectives: The aim of our study was the estimation of the useful- 
ness of the Mycoplasma IST test (bioMerieux) 1n the identification 
and drtermination of the sensitivity of mycoplasmas and urraplasmas 
to antibiotics. Mycuplasrna homirzis and Ureaplasma orealyticrrtn are 
important pathogens responsible for some urogenital infections 
among sexually active men and women. The isolation and determi- 
nation of susceptibility of these bacteria are very difficult because of 
their fastidious character and specific culture procedures. Therefore, 
looking for new diagnostic methods is extremely important. 
Methods and patients: 90 patients were e x a m i n e d 4 0  women 
were treated for reasonc of infertility in the Department of 
Gyiiecoloby of the Medical University and 50 patients with urogen- 
ital infections were diagnosed in the bacteriologic laboratory The 
materials used in this study were urethral and cervical swabs. 
Simultaneously with the cultiire procedures, the Mycoplasma IST 
test was performed. 
Results: Almost 100% conformity between classical and 
Mycopla\ma IST methods was obtained. M.  liominis and [ I  
itrcnlyticrrm were detected in 8.9% and 28.9% of examined patients 
respectively. High-level resistance to erythromycin of M .  huminis 
(87.5%) and U. urealyticirnr (53.8%) were observed. 
Conclusions: The Mycoplasma IST test was assessed positively. 
I t  is not time-consumiiig and it is simple to perform. This test enables 
simultaneous identification and determination of susceptibility 
Ip4031 Urogenital mycoplasmas: an increasing 
prevalence in maternity hospitals 
E. Zagotzidou, A. Voyatzi, E. Piperaki, M. Alexandrou. Alrxoiidril ' 
s Materrrity Hospital, Atlrens, Greece 
The purpose of this study is to record the frequency of infections 
caused by urogenital mycoplasinas from cervicovaginal samples of a 
maternity hospital. During the period 20 October 1997 to 20 
October 1998, 2806 cervical specimens were tested fix urogenital 
mycoplasinas. For the identification, enuiiieration and susceptibility 
testing, the mycoplasma IST (BioMCrieux) was utilized. In total, 826 
samples (29.45%) were determined to be positive with a titer of 10' 
CFU/niL. In addition, 243 samples (8.65%) were clas\ified as non- 
infectious colonization. The remaining 1737 sample\ (61.9'%1) were 
negative. The tests for detection of resistance were pedornied on the 
antibiotics tetracycline, doxycycline, ofloxacin, erythromycin, 
josaniycine and pristinaniycin. 
Conclusions: The prevalence of urogenital niycoplasnia infection 
in maternity hospitals is relatively high. The increase in resistancc to 
erythromycin must be assessed in the future, and it should not be used 
as an identification test. 
m] Prevalence of metronidazole-resistant 
Tricbomonas vaginalis in a gynecology clinic 
G. Schmid', E. Narcisi', D. Mosure', E. Secor', H. Morcno'. 
'Ceritcrs-fir Direose Contrul and Preuerrriurr, ZEnmy  Criivcrsity Ahool  of 
Medicine, Atlarim, GA, USA 
Background: Strains of Trichonionas uqitialis resistant to metronida- 
zole are known to exist, but their prevalence hix not been deter- 
mined. 
Objectives: To measure the prevalence of metronidazole resis- 
tance among isolates of T vqinalis and the response to therjpy wlth 
metronidazole, 2 g orally, once, in women infected with strains of 
varying resistance. 
Methods: Vaginal secretions were cultured in modified 
Diamond's medium and examined daily for 1 week. Isolates were 
tested by the method of Meingassner for metronidazole susceptibil- 
ity, expressed as the aerobic minimum lethal concentration (MLC). 
Results: Over a 2-month period, T ua~yinalis was isolated froin 82 
(9%) of 911 consecutive patients having a vaginal culture. O f  the 82 
isolates, 2 (2.4%) were resistant to metronidazole (MLC SO pg/mL). 
Of the 42 patients agreeing to return for culture 1 week following 
treatment, 26 did and all were cured, including 1 of the 2 patleiits 
with a resistant strain. 
Conclusions: Metronidazole-resistant strains of T uu,qirrn/ir 
occurred more comnionly than we had thought, and some are appar- 
ently cured by standard doses of metronidazole. 
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512 624 26 4.1 2 7-5.9 
20.29 94 25 3.1 2.0.4 7 
13.19 682 25 3.7 2 4 - 5 4  
vl T: vaginalis and bacterial flora in men with 
non-gonococcal urethritis 
I .  Haydouchka', N. Andreeva', M. Murdjeva', I. Vachkova', M. 
Draganov'. 'Higher Medical Institute, Plovdiv, zUniversity o f  Plovdiv, 
Bulgaria 
Objectives: To study the frequency of detection of 7: vaginalis, C. 
trachomatis and aerobic and facultatively anaerobic bacterial flora in 
patients with non-gonococcal urethritis as well as the structure of the 
associated infections. 
Methods: Urethral secretions from 97 men (aged from 19 to 57 
years) with urethritis were studied. Routine cultural, microscopic and 
identification methods were applied for the detection of T vaginalis 
and aerobic and facultatively anaerobic bacterial flora. C. trachomatis 
was demonstrated in the indirect immunofluorescent test, McCoy 
cell culture and ELISA. 
Results: Parasitologic and bacterial findings were proved in 86.5% 
of all examined patients. Mono-isolates were found in 64.9% of all 
cases and associated flora (two- and three-component associations) in 
21.6%. 7: vqinalis was detected in 17.5% of all patients. In 76.5% of 
these cases it was associated with bacterial flora; in 23.1% out ofthese 
associated infections the parasite was detected with C. trachomatis. C. 
trachomatis was the most frequent of all bacterial isolates (48.4%). It 
was found alone in 46.8% of all cases with chlamydial infections. Its 
associatiation with coagulase-negative staphylococci was prevalent 
(22.7%). Of other bacteria, the highest frequency of detection was 
for coagulase-negative staphylococci (35.1%), followed by Enterococcus 
spp. (17.5%). Streptococcus, bacteria from te Enterobacteriaceae, 
Candida spp. and S. aureus were rare isolates. 
Conclusions: Complex diagnostic investigations are a necessary 
step towards the precise etiologic diagnosis and adequate therapy of 
urethral inflammatory diseases. 
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Ip4061 Sexually transmitted diseases (STDs) and 
reproductive function 
664 14 2.1 1 1 - 3 5  
631 22 3.5 2 2 - 5 2  
569 31 5.1 3 7 - 7 6  
3974 143 3.6 3.1-4.2 
A. Zilevica, I. Ancupane, A. Miltins, I. Gornostajeva, A. Berzupe. 
Ltvian University, Riga, Latvia 
Objectives: To establish the mcrobial and viral etiology of genital 
infections with special reference to chronic infections. 
Methods: Urethral specimens were processed for detection of 
Neisseria gonorrhoeae by direct smear, and culture for detection of 
Chlamydia trachomatis by DFA, smears and the esterase test. Specimens 
were also inoculated on suitable culture media for isolation of 
Ureaplasma uerealyticum, Trichomonas vqinalis, Mycoplasma spp.. 
Candida spp. and Gardnerella vqinalis. HSV-1 and HSV-2 infection 
was detected serologically and in culture. 
Results: A total of 456 patients were examined. Viral and bacte- 
rial monoinfections were registered in 8% and 9% ofpatients, respec- 
tively. In other patients, mixed infections were observed. 29% of 
patients had viral and chlamydial infections. 54% of patients had 
mixed viral-bacterial infections with 3-8 causative agents of STD. 
Pelvic inflammatory diseases were associated mainly with N. gonor- 
rhoeae, M.  hominis, C. trachomatis and U. urealyticum infections. 
Conclusions: Early diagnosis and treatment of STD is the most 
important preventive measure for maintenance of reproductive func- 
tion. 
Ip4071 1s sexual transmission an important pattern for 
herpes simplex type 2 virus seroconversion in 
the Spanish general population? 
P. Garcia-Corbeira', R. Dal-Re', L. Aguilar', J.J. Granizo', J. 
Garcia-de-Lomas'. 'Medical Department, SmithKIine Beecham 
Pharmaceuticals, Madrid, ZDepartment of Microbiology, University Clinic 
Hospital and Medical School, Pblencia, Spain 
Objectives: To assess the seroprevalence of herpes simplex virus type 
2 (HSV-2) in the Spanish general population. 
Methods: A seroepidemiologic study of HSV-2 was performed 
on a representative sample (N=3974) of the Spanish population. The 
sample comprised 1922 men and 2052 women in the age range 5-59 
years, stratified by sex and age. Sera were screened for HSV-2-specific 
1gG antibodies by an enzyme-linked immunosorbent assay based on  
recombinant glycoprotein G2 (gG2). 
Results: Results are shown in the table: 
IP408] Survey on the organisms involved in vaginitis 
in a large maternity hospital 
M. Nyha, E. Zambeli, M. Dioudi, Ch. Nikolidaki, L. 
Zannopoulos, K. Aggiolina, P. Kostantakos, 0. Kreatsa. Clinical 
Microbiology Central Lboratoy, Mitera Maternity Hospital, Athem, 
Greece 
The most common causes ofvaginal infections are attributed to etio- 
logic agents such as U. urealyticum, M .  hominis, G. vaginalis, yeast, 
Chlamydia, Trichomonas vaginalis, and Gram-negative and Gram-posi- 
tive microorganisms. In a period of 2 years, the results of 6340 
cultures were stuhed for the aforementioned organisms. For the 
identification of these organisms, the MYCOPLASMAIST, API ID 
32 strips and the VIDAS CHLAMYDIA kits (BioMkrieux) were 
utilized. 
The results revealed the following frequencies: U. urealyticum 
31.2%, U .urealyticum and M. hominis 3.2%, M.  hominis 0.4%, yeasts 
24.3%, G. iiuginalis 18.5%. Gram negatives 8%, Gram positives 5%. 
Trichomonas vaginalis 2.45%, Chlamydia 6.95%. There are 50.9% mixed 
infections with mycoplasmas (mainly with G. vayinalis and yeasts), 
48.5% mixed infections with G. vaginalis (mainly with yeasts and 
mycoplasmas), 51% mixed infections with yeasts (mainly with G. 
vaginalis, Chlamydia and mycoplasmas), 27% mixed infections with 
Chlamydia (mainly with yeasts and Gram postives). 
The results confirm that vaginal infections are frequently due to 
more than one etiologic agent. Hence it is considered necessary to 
simultaneously test for the presence of more than one nlicroorgan- 
ism in each vaginal sample. 
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(p409( Use of roxithromycin in treatment of womens' 
inflammatory diseases of the genitals 
be applied according to the antibiogram Ofloxdcin i r  ureful for the 
empirical therapy of inflammations of the male genital organ< 
D.M. Seniyon. Vitehsk Statc hledtcul Institute, Vitebsk, Republic .f 
Belarus [q Prevalence of sexually transmitted diseases in 
a northern Italian area during the period 
1994-98 
Objectives: To study the efficiency of roxithromycin used for treat- 
ment of women with inflammatory diseases of the genitals of chlamy- 
dial etiology. 
Methods: 38 women with salpingoophoritis of chlamydial etiol- 
ogy were observed. 12 of them had Chlamydia and Ureaplasnta simul- 
taneously (Clilamydia trachomatir, Ureaplasma urealyticum). Chlamydia 
trachontatis and Mycoplasma huminis were revealed in 3 women. 
Diagnosis was suggested by gynecologic examination and laparo- 
scopy. The presence of chlamydial infection (Chlamydia trachomatis) 
was proven by polymerase chain reaction (PCR) and enzyme-linked 
iinmunoaorbent assay (ELISA) using MicroTrak test systems. 20 
women received 300 nig roxithromycin per day; the total dosage was 
1.8 g. 18 women received doxycycline in a daily dose of 0.2 g; the 
total dose was 2.8 g. The efficiency of roxithromycin and doxycy- 
cline was evaluated in a randomized study 
Results: The treatment was successful in 18 of 20 women (90%) 
using roxithromycin and in 10 of 18 women (56%) using doxycy- 
cline hydrochloride. Roxithromycin as ethyotropic treatment had no 
adverse effects or complications. Four of 18 women (22%) using 
doxycycline hydrochloride developed candidosis of vaginal mucus. 
Conclusions: Our study indicates the higher efficiency of 
roxithromycin for the treatment of patients with salpingoophoritis of 
chlaniydial and mixed (Chlamydia=Mycop/asma, Chlamydia= 
Ureaplasma) etiology compared with doxycycline hydrochloride. It is 
possible to prescribe roxithromycin as a remedy of choice for treat- 
ment of patients with salpingitis and salpingoophoritis caused by 
Chlamydia. 
S. Gualterotti, V. GiuffrC, M.M. Marzi. S. K p n i  Ospcdale Bassini, 
Cinisello Balsams, Milano, Italy 
Sexually transmitted diseases of the female lower genital tract are a 
highly complicated problem due to the continuous change in 
frequency and increased inigrational fluxes in recent years. In the 
present study, we examined 1458 women referred to the Gynecologic 
Day Hospital of Bassini Hospital in Cinisello Balsanio Milano (Italy) 
in the period from April 1994 to March 1998. During this period, 
the ethnic composition of the patients changed: the percentage of 
Italian woman decreased by 24%, while that of Africaiic increaxd by 
156%, Asians by 205%, and women from eastern Europe by 233%. 
1075 woinen were symptomatic, and 225 were asymptomatic (preg- 
nant). 75 came for a preconceptional screening and 25 for other 
reasons. The most frequent isolate was Carrdidu albiratrs (13.9'%), 
followed by Uveaplasma urealyticum (1 1.7%), Gardnrrc~lla vagitialis 
(10.6%), beta-heniolytic group A streptococci (5.7'%,), Trichotnorrus 
qqinalis (O.S%), and S. aureus (0.16%. No infections by AT pviorrltoeae 
were revealed in spite of the use of endocervical swabs, ar reported 
in the literature. 
Molecular typing 
(q Anaerobes and aerobes isolated from semen in 
infections of the male genital tract- 
susceptibility to antimicrobial agents 
A. Kokosz', T. Kosiec*, L.. Marianowski', E Meisel-MilkolaJczyk2. 
'Medical Academy, 'Bielanski Hospital, Warsaw, Poland 
Objectives: To perform bacteriologic analysis of senien from men 
with genital tract infection before and after treatment with ofloxacin. 
Methods: Samples of semen from 35 inen aged 21-42 years with 
clinical diagnosis of inflanmation of the genital organs before treat- 
ment with ofloxacin and samples from 22 of the same men 2 weeks 
after therapy were examined. Isolated strains were identified in the 
automatic ATE system. The susceptibility of strains to ofloxacin was 
determined with the disk diffusion method, and to other antiniicro- 
bids in the ATB system. 
Results: Out  of 35 semen samples from patients before treatment, 
100 bacterial strains were isolated: 71 aerobes and facultative anaer- 
obes, and 29 obligate anaerobes. Six strains resistant to ofloxacin were 
detected (6%). Out  of 22 semen samples from men after therapy, 50 
strains were cultured: 21 aerobes and facultative anaerobes and 29 
obligate anaerobes. The greatest number of isolated aerobes were 
staphylococci, and anaerobes peptostreptococci. Fourteen strains 
were resistant to ofloxacin (28%); 12 ofloxacin-resistant isolates were 
obligate anaerobes. Clinical examinations proved a high efficacy of 
ofloxacin applied for 20 days in a dose of 2 X200 nig. Recession of 
clinical symptoms and leukospermia were observed in 92% of 
patients. 
Gram-positive bacteria dominate in examined 
semen camples. Since, fiequently, several bacterial strains are cultured 
from the semen in cases of genital tract infections, the therapy should 
Conclusions: 
I P4 12 I Molecular epidemiology of Corynebacteriurn 
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Objectives: The largest diphtheria epidemic since the advent ofmass 
inununizdtion, which cornmenced in the eastern European region in 
1990, is still ongoing. There have been several imported cases of 
diphtheria from the former USSR to countries of weytern Europe. 
These epidemics have emphasized the importance of characterization 
studies to determine the clonality of Corynebacrcriruv diphtheriac 
and to provide information for epidemiologic and microbiological 
surveillance. 
Methods: A total of 423 isolates of C. diphtllcriae koin the 
European region were examined by biotyping, toxigenicity testing, 
ribotyping and pulsed-field gel electrophoresis (PFGE). Forty-five 
isolates that had produced 20 distinct ribotypes were analyzed further 
by random amplification of polymorphic DNA (RAPD) and 50 
isolates that produced seven distinct ribotypes were examined by 
amplified fragment length polymorphism (AFLP). 
Results: Ribotyping revealed 45 dirtinct patterns on the basis of 
a single hand difference. They were provisionally designated as 
Dl-D45. PFGE revealed 40 patterns on the basis of a three-band 
difference. There was 100% correlation between RAP11 profiles and 
ribotypes; AFLP could discriminate certain ribotypes even further. 
The predominant ribotypes in Kussia, D1, I14 and D7, have dirrenl- 
inated to neighboring and distant countries. PFGE, RAPD and 
AFLP results provide evidence to suggest a potential clonal relation- 
ship between D1 and D4. 
Conclusion: Several genotypes of C. diphtheriae are circulating 
within the European region. Ribotyping and PFGE are effective 
